0001144204-16-112017.txt : 20160707
0001144204-16-112017.hdr.sgml : 20160707
20160707164422
ACCESSION NUMBER: 0001144204-16-112017
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160706
FILED AS OF DATE: 20160707
DATE AS OF CHANGE: 20160707
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000810509
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 311080091
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5600 BLAZER PARKWAY
STREET 2: SUITE 200
CITY: DUBLIN
STATE: OH
ZIP: 43017
BUSINESS PHONE: 6147937500
MAIL ADDRESS:
STREET 1: 5600 BLAZER PARKWAY
STREET 2: SUITE 200
CITY: DUBLIN
STATE: OH
ZIP: 43017
FORMER COMPANY:
FORMER CONFORMED NAME: NEOPROBE CORP
DATE OF NAME CHANGE: 19940714
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDBERG MICHAEL M
CENTRAL INDEX KEY: 0000905011
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35076
FILM NUMBER: 161757000
MAIL ADDRESS:
STREET 1: C/O MONTAUR CAPITAL PARTNERS
STREET 2: 152 WEST 57TH STREET, 4TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
4
1
v443798_4.xml
OWNERSHIP DOCUMENT
X0306
4
2016-07-06
0
0000810509
NAVIDEA BIOPHARMACEUTICALS, INC.
NAVB
0000905011
GOLDBERG MICHAEL M
5600 BLAZER PARKWAY, SUITE 200
DUBLIN
OH
43017
1
0
0
0
Common Stock
2016-07-06
4
A
0
43580
0.50
A
403152
D
Acquired from Issuer in lieu of cash compensation for board services during the second quarter of 2016.
/s/ Kevin W. Waite
2016-07-07